MRK vs NVS: Fair Value Comparison

Merck & Company Inc vs. Novartis AG ADR · General Drug Manufacturers

MRK's model fair value sits 4.1% below its current price; NVS's model fair value sits 5.3% above its current price. Of the two, NVS trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

MRKNVS
Price$147.98$154.51
Model fair value (multi-method blend)$141.91$162.77
Model fair value differential-4.1%+5.3%
Methods with a model value above price4 of 76 of 9
Fundamental strengthBB+
Next earnings report2026-10-292026-10-27

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

LLY vs MRK · JNJ vs MRK · ABBV vs MRK · MRK vs AZN · LLY vs NVS · JNJ vs NVS · ABBV vs NVS · NVS vs AZN · All General Drug Manufacturers stocks · Compare any two stocks